Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi
Eli Lilly, maker of the anti-obesity drug Zepbound, announced last week the launch of LillyDirect, a direct-to-patient portal, allowing some patients to obtain its drug for as little...
China and Hong Kong have become the new focal point of the latest COVID-19 surge. China is enduring its first big outbreak of the Omicron variant and its “zero COVID” policy is bringing more pain with little gain. The...
